Browse the evidence

Performing one long resistance training session results in higher perceived effort and discomfort, but also higher session pleasure and preference compared to splitting the same workout into two shorter sessions.

If you enjoy feeling like you've worked hard, do one long session. If you prefer to feel less uncomfortable during the workout, split it. Both approaches are valid; choose based on your psychological preference.

A high-protein breakfast (34g) significantly increases subjective satiety and reduces hunger compared to a low-protein breakfast (6g) in young women with overweight, but this does not translate to reduced daily energy intake.

If you switch to a high-protein breakfast, you will likely feel fuller and less hungry in the hours after eating. However, be aware that this feeling of fullness may not automatically lead to eating less food throughout the rest of the day, as this study showed no difference in total daily energy intake.

Synchronous remote weight management interventions for adults with excess weight (BMI ≥ 27.5 kg/m2) face significant engagement barriers including privacy concerns, time burden, technical issues, and digital exclusion, which can be mitigated by facilitators such as digital competency, tailored feedback, convenience, and professional support.

To succeed with a remote weight management program, prioritize platforms that offer strong privacy protections, ease of use, and professional support. Address technical barriers by ensuring you have reliable internet and basic digital skills. Leverage features like self-monitoring and tailored feedback to maintain engagement, as these are key facilitators identified in the research.

The effectiveness of interventions on fiber intake diminishes over time, with higher effects observed at 9-24 months compared to 36 months and beyond.

If you join a dietary program, expect the biggest benefits in the first two years. To maintain these benefits long-term, you need to connect the program's lessons to your daily life and ongoing support systems, as the structured intervention's effect fades after 3 years.

Moderate or severe gastrointestinal (GI) adverse events during GLP-1 RA treatment are associated with a higher hazard of discontinuation and a lower rate of reinitiation.

GI side effects are a common reason for stopping GLP-1 RA. If you experience moderate or severe GI issues, talk to your provider about management strategies. These side effects are linked to higher discontinuation rates, but they can often be mitigated to help you stay on the medication.

In emerging economies like Vietnam, the rapid expansion of modern retail and increased availability of ultra-processed foods (UPFs) drives a shift toward unhealthy dietary patterns, contributing to rising obesity and diabetes rates.

For policymakers in emerging economies: Simply having traditional markets is not enough. You must actively regulate the expanding modern retail sector (supermarkets/convenience stores) through labeling, marketing restrictions, and fiscal incentives to ensure healthy food remains affordable and accessible compared to ultra-processed options.

Experts prioritize communication, education, and voluntary standards over strict regulatory constraints (like taxes or advertising bans) when designing food environment policies.

Policymakers should not rely solely on education and voluntary standards. To effectively combat the rise of UPFs, they must implement stricter regulatory measures like taxes and marketing restrictions, despite perceived feasibility challenges, as these are proven to be effective in other contexts.

Time-restricted eating (TRE) with a 10-hour window, when combined with caloric restriction, leads to greater lean mass loss compared to caloric restriction alone.

If you use a 10-hour eating window to lose weight, be aware that you might lose more muscle than if you just counted calories without a time limit. To counter this, ensure you are eating enough protein within your 10-hour window, perhaps spreading it out evenly.

Higher acculturation levels moderate the effectiveness of the MyPlate intervention, with the most acculturated participants showing the greatest reductions in waist circumference.

If you are recently immigrated or less acculturated to US food systems, standard MyPlate advice might be less effective for reducing belly fat. You may need more personalized guidance that integrates your traditional healthy foods with US dietary guidelines.

Personalized Type 2 Diabetes management, which tailors pharmacotherapy to individual phenotypic, clinical, and personal factors, improves medication adherence, patient satisfaction, and health outcomes compared to rigid algorithmic approaches.

Work with your doctor to build a treatment plan that fits your specific health profile (like kidney or heart status) and your personal life (like fear of hypoglycemia or preference for pills vs. injections). This collaborative approach leads to better adherence and fewer complications than following a generic, one-size-fits-all checklist.

Personalized glycemic targets should be less aggressive in older patients or those with reduced life expectancy to minimize hypoglycemia risk and polypharmacy burden.

If you are older or have other serious health conditions, your doctor may aim for a higher blood sugar target to keep you safe from dangerous lows and side effects. This focuses on your quality of life rather than just a number.

Home-based training (HBT) is a viable alternative to supervised exercise training (SET) when SET is not feasible, provided it is structured and monitored.

If you can't go to a supervised program, start a home-based walking plan. Walk 3 times a week, starting with 20 minutes and building up to 60. Use a pedometer or smartwatch to track your activity, and consider logging your pain levels. This is just as effective as supervised exercise if you monitor yourself.

A 3-year worksite lifestyle intervention significantly improves cardiovascular health metrics in middle-aged adults, but the effect attenuates to non-significance after the first year when intervention intensity is reduced.

If you are implementing a lifestyle change for heart health, expect significant benefits in the first year if you engage actively with coaching and tracking tools. However, do not assume these benefits will persist automatically if you stop engaging with the program after the first year. To maintain gains, you must either continue with periodic check-ins or independently maintain the high level of behavioral effort established during the initial intensive phase.

A lifestyle intervention is effective in improving cardiovascular health metrics in individuals with low baseline subclinical atherosclerosis, but ineffective in those with high baseline subclinical atherosclerosis.

If you have significant underlying cardiovascular disease (high subclinical atherosclerosis), standard lifestyle advice (diet, exercise, no smoking) may not be enough to improve your health metrics. You likely need more intensive, specialized medical or behavioral interventions. Do not assume that standard lifestyle changes will yield the same results as they do for healthier individuals.

Adherence to low-carbohydrate (LCD) and very low-carbohydrate ketogenic diets (VLCKD) is significantly lower than adherence to vegan or vegetarian diets, with attrition rates often exceeding 40-60% in long-term trials, leading to a convergence of metabolic outcomes between diet groups over time.

If you are trying a low-carb or keto diet for diabetes or weight loss, expect that sticking to it is the hardest part. Many people drop out or stop strictly following the diet within a year, causing their results to look like those of people on other diets. To succeed, focus on sustainability over perfection. If strict keto (<50g carbs) feels too restrictive or socially isolating, a moderate low-carb approach (<130g carbs) might be easier to maintain long-term, even if the initial weight loss is slower. The key is not the specific number of grams, but your ability to keep the diet going.

Short sleep duration (<5 hours) and long sleep duration (>9 hours) are independently associated with a significantly increased risk of acute stroke, exhibiting a U-shaped relationship where short sleep shows a higher magnitude of association on univariate analysis but attenuates more than long sleep after adjusting for comorbidities.

Aim for 7 hours of sleep per night. Both sleeping less than 5 hours and more than 9 hours is associated with a significantly higher risk of stroke. If you consistently sleep outside this range, consider it a modifiable risk factor for cardiovascular health, especially if you have other risk factors like hypertension.

Symptoms of Obstructive Sleep Apnea (snoring, snorting, breathing cessation) and a derived OSA score of 2-3 are significantly associated with increased odds of acute stroke, independent of a formal OSA diagnosis.

If you or your partner notice loud snoring, gasping, or pauses in breathing during sleep, seek medical evaluation. These symptoms are strongly linked to stroke risk, even if you haven't been diagnosed with sleep apnea. Addressing these symptoms may reduce stroke risk.

A higher cumulative burden of sleep disturbance symptoms (Sleep Disturbance Symptom Burden >5) is associated with a graded, significantly increased risk of acute stroke, with the highest burden showing an OR of 5.38.

If you experience multiple sleep problems (e.g., short/long sleep, poor quality, snoring, napping), your stroke risk increases significantly. The more symptoms you have, the higher the risk. Seek a comprehensive sleep evaluation to address all symptoms, not just one.

Lifestyle interventions alone are difficult to maintain long-term for weight loss in patients with T2DM and CKD, whereas GLP-1 RAs offer a pharmacological alternative with proven metabolic and organ protection benefits.

While lifestyle changes are important, they are hard to keep up long-term. GLP-1 RAs can help you maintain weight loss and protect your heart and kidneys, making it easier to stick to healthy habits. Talk to your doctor about whether a GLP-1 RA is right for you.

Anti-obesity medications (AOMs) including GLP-1 receptor agonists (liraglutide, semaglutide) and other agents (naltrexone-bupropion, phentermine-topiramate, orlistat) are significantly underutilized in clinical practice, with only 8% of eligible patients receiving a prescription and 4.4% filling it.

If you have obesity (BMI ≥30) and are interested in anti-obesity medications (AOMs) like GLP-1 agonists (e.g., semaglutide, liraglutide), be aware that access is heavily restricted by insurance type and demographics. In this study, only 8% of eligible patients got a prescription, and 4.4% filled it. If you are insured by Medicaid, Medicare, or are a minority, you face significantly lower odds of receiving these medications. Discuss these barriers with your provider and advocate for coverage options, as private insurance offers better access than public programs.

Discontinuation rates for weight-reducing (WR) diabetes-specific medications are nearly twice as high as those for weight-inducing (WI) medications, indicating poor persistence with preferred therapies.

If you start a weight-reducing diabetes medication, be prepared for a higher chance of stopping it compared to older weight-gain drugs. This is common, so don't be discouraged. Talk to your doctor about managing side effects, starting with a lower dose, or switching to an oral formulation if injections are the issue. Persistence is key to seeing long-term benefits.

Urban design that promotes physical activity and provides green space reduces cardiovascular mortality and risk factors, whereas urban environments that hinder activity and lack green space increase risk.

Prioritize living in or visiting areas with significant tree canopy and green space. If you live in a dense urban area, seek out parks and green corridors. These spaces not only encourage physical activity but also mitigate heat stress and air pollution, directly lowering cardiovascular risk.

Significant initial weight loss (decrease in BMI) is a strong predictor of high adherence to liraglutide treatment.

If you experience significant weight loss in the first few months of liraglutide treatment, you are much more likely to stick with the medication long-term. This positive feedback loop is a key factor in maintaining adherence.

Higher socioeconomic status and non-smoking status are significantly associated with higher adherence to liraglutide treatment.

Patients with higher income/education levels and those who do not smoke are more likely to adhere to their liraglutide prescription. Addressing financial barriers and supporting smoking cessation may improve adherence rates.